Clinical Trials on Islet Cell Transplantation

Total 33736 results

Kim, Seoung-Hoon
Astellas Pharma Korea, Inc.; Linical Korea

Completed

To Evaluate the Efficacy and Safety of ADVAGRAF® After Treatment With a Tacrolimus in New Liver Transplant Recipients

Liver Transplantation
Bristol-Myers Squibb
Heidelberg University

Completed

Belatacept in Renal Transplantation: Analyses Using Data From the Collaborative Transplant Study (CTS)

Kidney Transplantation
Novartis Pharmaceuticals

Completed

Efficacy and Safety of FTY720 in Patients Who Receive a Kidney Transplant

Kidney Transplantation

United States
Novartis Pharmaceuticals

Completed

Efficacy and Safety of FTY720 in de Novo Adult Renal Transplant Recipients

Renal Transplantation
Central Hospital, Nancy, France

Completed

Measurements of Myocardial Relaxation Time by MRI During Respiration (ARTEMIS)

Heart Transplantation

France
Ann & Robert H Lurie Children's Hospital of Chicago
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Pediatric Heart Transplantation: Transitioning to Adult Care (TRANSIT)

Heart Transplantation

United States
National Institute of Allergy and Infectious Diseases...
Clinical Trials in Organ Transplantation in Children

Completed

Perceived Barriers to Patient Adherence After Pediatric Solid Organ Transplantation

Organ Transplantation

United States
Khon Kaen University
National Science and Technology Development Agency, Thailand

Unknown

Clinical Trial in Assigning of Tacrolimus Dosage Regimen According to CYP3A5 Genotype in Kidney Transplant Recipients

Kidney Transplantation

Thailand
Novartis

Completed

A Twelve-month, Multicenter, Open-label, Randomized Study of the Safety, Tolerability and Efficacy of Everolimus With Basiliximab, Corticosteroids and Two Different Exposure Levels of Tacrolimus in de Novo Renal Transplant Recipients

Renal Transplantation

Switzerland
Novartis Pharmaceuticals

Completed

Study of Enteric-coated Mycophenolate Sodium (EC-MPS) With Cyclosporine Microemulsion and Steroids in Pediatric de Novo Renal Transplant Patients

Kidney Transplantation

Switzerland
Novartis Pharmaceuticals

Completed

Efficacy and Safety of AEB071 Versus Cyclosporine in de Novo Renal Transplant Recipients

Kidney Transplantation

Belgium, Taiwan, Italy, Germany, Spain, Switzerland, Australia, Singapore, Norway, Netherlands, Colombia, Argentina, Brazil, Austria, Slovakia, France, Czech Republic
Novartis

Completed

Extension Study of Enteric-coated Mycophenolate Sodium With Short-term or no Steroid Use Compared With Enteric-coated Mycophenolate Sodium With Standard Steroid Therapy in de Novo Kidney Recipients

Renal Transplantation
Hoffmann-La Roche

Completed

A Study of Mycophenolate Mofetil (CellCept) in Lung Transplant Recipients

Lung Transplantation

Germany
Hoffmann-La Roche

Completed

An Observational Study of CellCept (Mycophenolate Mofetil) in Renal Allograft Recipients

Kidney Transplantation

Serbia
University Hospital, Ghent
Roche Pharma AG

Completed

Individually Adapted Immunosuppression in de Novo Renal Transplantation Based on Immune Function Monitoring: a Prospective Randomised Study (CD4-01)

Kidney Transplantation

Belgium
Hopital Foch

Terminated

Closed-loop Anesthesia, Using Bispectral Index as the Control Variable, During Liver Transplantation (Drone-TH)

Liver Transplantation

France
University Hospital, Limoges
Hannover Medical School; KU Leuven; Hospital Purpan; Hôpital Necker-Enfants Malades

Unknown

BIOMARGIN European, Ambispective Cohort of Adult and Paediatric Renal Transplant Patients (BECS)

Kidney Transplantation

Belgium, France, Germany
Seoul National University Hospital
Ministry of Food and Drug Safety, Korea

Unknown

Validation of Population Pharmacokinetic Model Derived From Healthy Volunteer in Kidney Transplant Recipients

Kidney Transplantation

Korea, Republic of
Mayo Clinic
Millennium Pharmaceuticals, Inc.

Completed

The Impact of Velcade(TM)on Antibody Secreting Cells in Sensitized Renal Allograft Candidates

Kidney Transplantation

United States
Astellas Pharma Inc

Completed

A Study to Compare the Efficacy and Safety of FK506MR vs Prograf® in Patients Undergoing Kidney Transplantation

Kidney Transplantation

China
Astellas Pharma Inc

Completed

A Study to Compare the Efficacy and Safety of FK506MR vs Prograf® in Patients Undergoing Liver Transplantation

Liver Transplantation

China
University of Cincinnati
Genzyme, a Sanofi Company; Millennium Pharmaceuticals, Inc.

Completed

Randomized Trial of Induction Therapies in High Immunological Risk Kidney Transplant Recipients

Kidney Transplantation

United States
Hoffmann-La Roche

Completed

A Study to Assess Immune Response in Pediatric Kidney Transplant Recipients Treated With Daclizumab (Zenapax)

Kidney Transplantation

United States
University of Manchester
Manchester University NHS Foundation Trust

Completed

GDT Vs ST for Pancreas Transplant Surgery

Pancreas Transplantation

United Kingdom
Tampa General Hospital

Unknown

Patient Education Study to Determine Knowledge Acquisition in Patients Preparing to Undergo Lung Transplantation

Lung Transplantation

United States
Hoffmann-La Roche

Completed

CLEAR Study - A Study of CellCept (Mycophenolate Mofetil) in Recipients of Kidney Transplants

Kidney Transplantation

Canada
Astellas Pharma Inc

Completed

Comparing Efficacy and Safety of Steroid Withdrawal With Tacrolimus and MMF With Induction in Children After Kidney Transplantation (TWIST)

Kidney Transplantation

Belgium, Italy, Taiwan, France, South Africa, Turkey, Germany, United Kingdom, Hungary, Czech Republic, Romania, Sweden, Poland, Israel
Asan Medical Center

Unknown

The Usefulness of Tacrolimus Without Basiliximab in Well Matched Living Renal Transplantation in Korea

Kidney Transplantation

Korea, Republic of
University Hospital, Basel, Switzerland

Completed

Comparison of ATG to Thymoglobuline in Renal Transplantation

Transplantation, Kidney

Switzerland
Emory University

Terminated

Hand Transplantation for the Reconstruction of Below the Elbow Amputations (VCA-01)

Amputation | Transplantation

United States
IRCCS Policlinico S. Matteo

Completed

Effect of Different Therapeutic Strategies on Regulatory T Cells in Kidney Transplantation (EVERTWIST)

Kidney Transplantation

Italy
Novartis Pharmaceuticals

Completed

Everolimus in de Novo Heart Transplant Recipients (EVERHEART)

Cardiac Transplantation

Italy
University of Colorado, Denver
Novartis Pharmaceuticals

Withdrawn

Differentiating Everolimus Versus Sirolimus in Combination With Calcineurin Inhibitors in Kidney Transplant Patients (DESIRE)

Kidney Transplantation
Astellas Pharma Inc
Astellas Pharma Canada, Inc.

Completed

Study of Immunosuppressive Therapy Toxicities in Kidney Transplant Recipients at Regional or Satellite Community Clinics

Kidney Transplantation

Canada
Astellas Pharma Inc
Astellas Pharma Canada, Inc.

Terminated

Effect of Rapid Steroid Withdrawal on Subclinical Markers of Rejection

Kidney Transplantation

Canada
Astellas Pharma Inc
Astellas Pharma Europe B.V.

Completed

Comparing Efficacy & Safety of Tacrolimus & MMF With/Without Induction in the Elderly Following Kidney Transplantation. (SENIOR)

Kidney Transplantation

Belgium, France, Germany, Spain, Switzerland, United Kingdom, Netherlands
Astellas Pharma Inc

Completed

Comparing Efficacy & Safety of Tacrolimus With/Without MMF or Monoclonal Anti-IL2R Antibody in Liver Transplantation. (MARSILEA)

Liver Transplantation

Belgium, Germany, Italy, Switzerland, Spain, Denmark, United Kingdom, Hungary, Finland, Sweden, Poland
Astellas Pharma Inc

Completed

Tacrolimus and Daclizumab Versus Tacrolimus and Steroids in Liver Recipients Receiving Sub-optimal Grafts (PANTERA)

LIVER TRANSPLANTATION

Italy
Astellas Pharma Inc

Completed

Sequential Therapy (FK506 + Monoclonal Anti-IL2R Antibodies + MMF) Versus FK506 With Steroids in Liver TX (TAST)

Liver Transplantation

Italy
University Health Network, Toronto

Unknown

Duct-to-duct vs Roux-en-y Hepaticojejunostomy for Biliary Reconstruction in Adult Living Donor Liver Transplantation

Liver Transplantation

Canada
Astellas Pharma Inc

Completed

A Study to Evaluate the Safety and Efficacy of FK506E (MR4) in Patients Undergoing Primary Liver Transplantation.

Liver Transplantation

France, Italy, Poland, Belgium, Spain, Germany, Switzerland, Canada, Finland, Brazil, Czech Republic, Australia, Norway, Sweden, United Kingdom, Ireland
Astellas Pharma Inc

Completed

A Study to Evaluate the Safety and Efficacy of FK506E (MR4) in Patients Undergoing Primary Kidney Transplantation

Kidney Transplantation

Australia, France, United Kingdom, Germany, Spain, Argentina, South Africa, Switzerland, Canada, Finland, Greece, Netherlands, Brazil, Belgium, Poland, Hungary, Czech Republic, Austria, Ireland, Italy, Mexico, Norway, Sweden
Pfizer

Completed

Study Evaluating The Use Of Sirolimus In Recipients Of Kidney Allografts From Expanded Criteria Donors (ECD)

Renal Transplantation

Argentina
Samsung Medical Center

Completed

Vecuronium Requirements According to the Operation Phase During Liver Transplantation Under Desflurane Anesthesia

Liver Transplantation

Korea, Republic of
Hospital Clinic of Barcelona

Terminated

Pilot Study of Immunosuppression Drug Weaning in Liver Recipients Exhibiting Biomarkers of High Likelihood of Tolerance

Liver Transplantation

Spain
Astellas Pharma Inc

Completed

Comparative Study of Modified Release (MR) Tacrolimus/Mycophenolate Mofetil (MMF) in de Novo Kidney Transplant Recipients

Kidney Transplantation

United States, Canada, Brazil
National Institute of Diabetes and Digestive and...

Completed

Combination Drug Therapy Followed by Single Drug Steroid Free Therapy to Prevent Organ Rejection in Kidney Transplantation

Kidney Transplantation

United States
University of California, San Francisco

Withdrawn

Transversus Abdominis Plane (TAP) Block After Kidney Transplantation

Transplantation, Kidney

United States
Hannover Medical School

Completed

Patient Education After Lung Transplantation Via Tablet Computers Versus Conventional Education

Lung Transplantation

Germany
University Hospital, Limoges

Completed

Reduction in the Risk of Rejection by Mycophenolate Mofetil Dose Adjustment in Liver Transplant Patients With Side Effects Caused by the Calcineurine Inhibitors (MONOCEPT)

Liver Transplantation

France

3

Subscribe